Sanjay Nayak Ocular Therapeutix, Inc (OCUL) insider trading activity

Sanjay Nayak is Chief Strategy Officer of OCULAR THERAPEUTIX, INC. Currently has a direct ownership of 279,738 shares of OCUL, which is worth approximately $3.27 Million. The most recent transaction as insider was on Aug 25, 2025, when has been sold 1,885 shares (Common Stock) at a price of $12.04 per share, resulting in proceeds of $22,695. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 280K

0.67% 3M change

58.77% 12M change

Total Value Held $3.27 Million

Sanjay Nayak Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 25 2025	SELL Open market or private sale	$22,695 $12.04 p/Share	1,885 Reduced 0.67%	279,738 Common Stock
May 23 2025	SELL Open market or private sale	$13,350 $7.17 p/Share	1,862 Reduced 0.66%	281,623 Common Stock
Feb 24 2025	SELL Open market or private sale	$12,961 $6.84 p/Share	1,895 Reduced 0.66%	283,485 Common Stock
Feb 11 2025	BUY Grant, award, or other acquisition	-	111,000 Added 28.0%	285,380 Common Stock
Nov 25 2024	SELL Open market or private sale	$16,326 $9.0 p/Share	1,814 Reduced 1.03%	174,380 Common Stock
Aug 23 2024	SELL Open market or private sale	$16,524 $9.02 p/Share	1,832 Reduced 1.03%	176,194 Common Stock
May 23 2024	SELL Open market or private sale	$13,280 $5.84 p/Share	2,274 Reduced 1.26%	178,026 Common Stock
Feb 22 2024	BUY Grant, award, or other acquisition	-	80,300 Added 30.81%	180,300 Common Stock

Sanjay Nayak

Chief Strategy Officer

Bedford, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUL shares.

Notify only if

Value

Insider Trading

Get notified when an Ocular Therapeutix, Inc insider buys or sells OCUL shares.

Notify only if

Operation

Value

Type

News

Receive news related to OCULAR THERAPEUTIX, INC

Track Activities on OCUL

Account